Unterehmen auf Watchlist setzen
Sapiens
ISIN: KYG7T16G1039
WKN: A2N4QA
Curious about what AI knows about Sapiens? Just one click more
More AI Integrations
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Sapiens · ISIN: KYG7T16G1039 · PR Newswire (ID: 20241111LN50842)
11 November 2024 11:43AM

Sapiens Reports Third Quarter 2024 Financial Results


ROCHELLE PARK, N.J., Nov. 11, 2024 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2024.

Sapiens Logo

 

Summary Results for Third Quarter 2024 (USD in millions, except per share data)



GAAP

Non-GAAP



Q3 2024

Q3 2023

% Change

Q3 2024

Q3 2023

% Change

Revenue

$137.0

$130.7

4.8 %

$137.0

$130.8

4.8 %

Gross Profit

$60.3

$56.0

7.8 %

$62.8

$59.3

6.0 %

Gross Margin

44.0 %

42.8 %

 120 bps

45.8 %

45.3 %

50 bps

Operating Income

$21.7

$20.3

7.3 %

$25.1

$24.1

4.3 %

Operating Margin

15.9 %

15.5 %

 40 bps

18.3 %

18.4 %

-10 bps

Net Income (*)

$18.3

$15.9

15.5 %

$21.1

$19.1

10.5 %

Diluted EPS

$0.33

$0.28

17.9 %

$0.37

$0.34

8.8 %



(*) Attributable to Sapiens' shareholders

 

Roni Al-Dor, President and CEO of Sapiens, stated, "This quarter showcased solid performance in our key regions. We are pleased to report that revenue reached $137 million this quarter, reflecting a 4.8% increase over the same period last year. Revenue growth was driven by 7.1% growth in our European region, 1.7% growth in North America and 6.6% growth in ROW regions. This quarter's non-GAAP operating profit totaled $25 million, representing 18.3% of total revenue." 

Mr. Al-Dor continued, "Revenue fell short of our targets in the third quarter, and the challenges we encountered are expected to impact revenue in the fourth quarter. Today, we are revising our 2024 non-GAAP revenue guidance to a range of $541 million to $546 million, down from the previous range of $550 million to $555 million - a 1.6% reduction at the midpoint. However, we expect our non-GAAP operating margin to be within our guidance range at 18.2%. Looking into 2025, we anticipate a low single-digit revenue growth." 

Quarterly Results Conference Call

Management will host a conference call and webcast on November 11, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

     North America (toll-free): 1-888-642-5032

     International: 972-3-9180644

     UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: https://veidan.activetrail.biz/sapiensq2-2024. A replay of the call will be available one business day following the completion of the event at the same link for 90 days.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Annual Recurring Revenue ("ARR") as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

 The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance software solutions. With Sapiens' robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. We help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers' compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative SaaS offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success.

Investor and Media Contact

 

Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of

Investor Relations, Sapiens

Yaffa.cohen-ifrah@sapiens.com

+1 917-533-4782

Investor Contacts

 

Brett Maas

Managing Partner, Hayden IR

+1 646-536-7331

Brett.Maas@HaydenIR.com

 

Kimberly Rogers

Managing Director, Hayden IR

+1 541-904-5075

kim@HaydenIR.com

 

Forward Looking Statements

Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to:  the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; the global macroeconomic environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements, and uncertain economic conditions, and their impact on our revenues, profitability and cash flows; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the coronavirus epidemic,  and fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.

While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2023, to be filed in the near future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 



SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES                   

CONDENSED CONSOLIDATED STATEMENT OF INCOME                   

U.S. dollars in thousands (except per share amounts)











  Three months ended



  Nine months ended







 September 30,



 September 30,







2024



2023



2024



2023







 (unaudited)



 (unaudited)



 (unaudited)



 (unaudited)





















 Revenue



137,025



130,705



408,074



383,725

 Cost of revenue



76,729



74,753



230,114



220,080





















 Gross profit



60,296



55,952



177,960



163,645





















 Operating expenses:



















 Research and development, net



16,449



16,028



49,779



47,391



 Selling, marketing, general and administrative



22,101



19,659



64,030



57,475

 Total operating expenses



38,550



35,687



113,809



104,866





















 Operating income



21,746



20,265



64,151



58,779





















 Financial and other (income) expenses, net



(913)



551



(3,114)



2,310

 Taxes on income



4,324



3,710



12,812



10,627









































 Net income



18,335



16,004



54,453



45,842





















 Attributable to non-controlling interest



-



132



141



371





















 Net income attributable to Sapiens' shareholders



18,335



15,872



54,312



45,471









































 Basic earnings per share



0.33



0.29



0.97



0.82





















 Diluted earnings per share



0.33



0.28



0.97



0.82







































Weighted average number of shares outstanding used to

compute basic earnings per share (in thousands)



55,854



55,397



55,799



55,251



















Weighted average number of shares outstanding used to

compute diluted earnings per share (in thousands)



56,308



55,813



56,151



55,657

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)







Three months ended



Nine months ended





September 30,



September 30,





2024



2023



2024



2023





(unaudited)



(unaudited)



(unaudited)



(unaudited)



















GAAP revenue



137,025



130,705



408,074



383,725

Valuation adjustment on acquired deferred

revenue



-



55



-



165

Non-GAAP revenue



137,025



130,760



408,074



383,890



















GAAP gross profit



60,296



55,952



177,960



163,645

Revenue adjustment



-



55



-



165

Amortization of capitalized software



1,470



1,418



4,584



4,274

Amortization of other intangible assets



1,043



1,835



3,630



5,531

Non-GAAP gross profit



62,809



59,260



186,174



173,615



















GAAP operating income



21,746



20,265



64,151



58,779

Gross profit adjustments



2,513



3,308



8,214



9,970

Capitalization of software development



(1,834)



(1,638)



(5,374)



(4,975)

Amortization of other intangible assets



1,276



1,074



3,732



3,234

Stock-based compensation



646



1,038



2,229



2,960

Acquisition-related costs *)



754



11



1,248



21

Non-GAAP operating income



25,101



24,058



74,200



69,989



















  GAAP net income attributable to Sapiens'

shareholders



18,335



15,872



54,312



45,471

  Operating income adjustments



3,355



3,793



10,049



11,210

  Taxes on income



(599)



(585)



(1,808)



(1,738)

  Non-GAAP net income attributable to Sapiens'

shareholders



21,091



19,080



62,553



54,943

 (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

 

Adjusted EBITDA Calculation

U.S. dollars in thousands









Three months ended



Nine months ended





 September 30,



 September 30,





2024



2023



2024



2023



















GAAP operating profit



21,746



20,265



64,151



58,779



















Non-GAAP adjustments:

















Valuation adjustment on acquired deferred revenue



-



55



-



165

Amortization of capitalized software



1,470



1,418



4,584



4,274

Amortization of other intangible assets



2,319



2,909



7,362



8,765

Capitalization of software development



(1,834)



(1,638)



(5,374)



(4,975)

Stock-based compensation



646



1,038



2,229



2,960

Compensation related to acquisition and acquisition-related costs



754



11



1,248



21



















Non-GAAP operating profit



25,101



24,058



74,200



69,989



















Depreciation



1,288



719



3,480



2,750



















Adjusted EBITDA



26,389



24,777



77,680



72,739

 

 

Summary of NON-GAAP Financial Information 

U.S. dollars in thousands (except per share amounts)





Q3 2024



Q2 2024



Q1 2024



Q4 2023



Q3 2023





















Revenues

137,025



136,800



134,249



130,914



130,760

Gross profit

62,809



62,481



60,884



59,370



59,260

Operating income

25,101



24,836



24,263



24,152



24,058

Adjusted EBITDA

26,389



25,931



25,360



25,267



24,777

Net income to Sapiens' shareholders

21,091



21,041



20,421



20,081



19,080





















Diluted earnings per share

0.37



0.37



0.36



0.36



0.34

 

 

Annual Recurring Revenue ("ARR")

U.S. dollars in thousands 









Three months ended





September 30,





2024





2023



Annual Recurring Revenue



173,414







157,589



















 

 

Non-GAAP Revenues by Geographic Breakdown

U.S. dollars in thousands



Q3 2024



Q2 2024



Q1 2024



Q4 2023



Q3 2023





















North America

55,755



57,918



55,158



54,882



54,848

Europe

69,281



66,072



68,727



65,239



64,662

Rest of the World

11,989



12,810



10,364



10,793



11,250





















Total

137,025



136,800



134,249



130,914



130,760

 

 







Non-GAAP Revenue breakdown





 U.S. dollars in thousands

 













Three months ended



Nine months ended







September 30,



September 30,







2024



2023



2024



2023

























Software products and re-occurring post-production services (*)

100,707



87,356



292,992



251,757





Pre-production implementation services (**)

36,318



43,404



115,082



132,133

























Total Revenues

137,025



130,760



408,074



383,890



























Three months ended



Nine months ended







September 30,



September 30,







2024



2023



2024



2023

























Software products and re-occurring post-production services (*)

53,809



46,053



156,386



133,339





Pre-production implementation services (**)

9,000



13,207



29,788



40,276

























Total Gross profit

62,809



59,260



186,174



173,615



























Three months ended



Nine months ended



September 30,



September 30,



2024



2023



2024



2023

















Software products and re-occurring post-production services (*)

53.4 %



52.7 %



53.4 %



53.0 %

Pre-production implementation services (**)

24.8 %



30.4 %



25.9 %



30.5 %

















Gross Margin

45.8 %



45.3 %



45.6 %



45.2 %



(*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature. 

(**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

 

 

Adjusted Free Cash-Flow

U.S. dollars in thousands





Q3 2024



Q2 2024



Q1 2024



Q4 2023



Q3 2023





















Cash-flow from operating activities

13,083



8,545



18,488



38,646



3,988

Increase in capitalized software development costs

(1,834)



(1,823)



(1,717)



(1,543)



(1,638)

Capital expenditures

(1,125)



(666)



(466)



(421)



(696)

Free cash-flow

10,124



6,056



16,305



36,682



1,654





















Cash payments attributed to acquisition-related costs(*) (**)

124



134



751



221



-





















Adjusted free cash-flow

10,248



6,190



17,056



36,903



1,654

(*) Included in cash-flow from operating activities

(**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

 

 



SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands











September 30,



December 31,







2024



2023







 (unaudited)



 (unaudited)













 ASSETS























 CURRENT ASSETS











Cash and cash equivalents



146,152



126,716



Short-term bank deposit



39,800



75,400



Trade receivables, net and unbilled receivables



109,670



90,273



Other receivables and prepaid expenses



25,769



22,514















Total current assets



321,391



314,903













 LONG-TERM ASSETS











Property and equipment, net



11,431



12,661



Severance pay fund



3,446



3,605



Goodwill and intangible assets, net



310,533



317,352



Operating lease right-of-use assets



20,502



23,557



Other long-term assets



15,993



17,546















Total long-term assets



361,905



374,721













 TOTAL ASSETS



683,296



689,624













LIABILITIES AND EQUITY





















 CURRENT LIABILITIES











Trade payables



8,224



6,291



Current maturities of Series B Debentures



19,796



19,796



Accrued expenses and other liabilities



80,610



77,873



Current maturities of operating lease liabilities



5,861



6,623



Deferred revenue



32,810



38,541















Total current liabilities



147,301



149,124













 LONG-TERM LIABILITIES











Series B Debentures, net of current maturities



19,778



39,543



Deferred tax liabilities



7,938



10,820



Other long-term liabilities



11,399



11,538



Long-term operating lease liabilities



17,532



21,084



Accrued severance pay



8,039



7,568















Total long-term liabilities



64,686



90,553













EQUITY





471,309



449,947













TOTAL LIABILITIES AND EQUITY



683,296



689,624











 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands





For the nine months ended

September 30,



2024



2023



(unaudited)



(unaudited)

Cash flows from operating activities:







Net income

54,453



45,842

Reconciliation of net income to net cash provided by operating activities:







Depreciation

3,480



2,750

Amortization of capitalized software and other intangible assets

11,946



13,039

Accretion of discount on Series B Debentures

32



47

Capital loss from sale of property and equipment

13



83

Stock-based compensation related to options issued to employees

2,229



2,960









Net changes in operating assets and liabilities, net of amount acquired:







Increase in trade receivables, net and unbilled receivables

(20,640)



(8,698)

Decrease in deferred tax liabilities, net

(2,280)



(1,410)

Increase in other operating assets

(908)



(4,107)

Increase (decrease) in trade payables

1,989



(616)

Decrease in other operating liabilities

(5,154)



(10,110)

Increase (decrease) in deferred revenues

(5,684)



363

Increase in accrued severance pay, net

640



636









Net cash provided by operating activities

40,116



40,779









Cash flows from investing activities:







Purchase of property and equipment

(2,306)



(2,145)

Proceeds from (investment in) deposits

36,360



(55,379)

Proceeds from sale of property and equipment

49



40

Payments for business acquisitions, net of cash acquired

(375)



-

Capitalized software development costs

(5,374)



(4,975)

Acquisition of intellectual property

-



(177)









Net cash provided by (used in) investing activities

28,354



(62,636)









Cash flows from financing activities:







Proceeds from employee stock options exercised

98



4,755

Distribution of dividend

(29,789)



(28,144)

Repayment of Series B Debenture

(19,796)



(19,796)

Acquisition of non-controlling interest

(4,131)



-

Dividend to non-controlling interest

-



(47)









Net cash used in financing activities

(53,618)



(43,232)









Effect of exchange rate changes on cash and cash equivalents

4,584



1,865









Increase (decrease) in cash and cash equivalents

19,436



(63,224)

Cash and cash equivalents at the beginning of period

126,716



160,285









Cash and cash equivalents at the end of period

146,152



97,061

 

Debentures Covenants

As of September 30, 2024, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

Covenant 1 

  • Target shareholders' equity (excluding non-controlling interest): above $120 million.
  • Actual shareholders' equity (excluding non-controlling interest) equal to $471.3 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to (44.90)%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.42).

Logo: https://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2024-financial-results-302301087.html

SOURCE Sapiens International Corporation

Visuelle Wertentwicklung / Kursverlauf · Sapiens
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
MIC: XNAS
Power-Shortcuts

Sapiens International Corporation N.V.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942